Search Within

Min Yuen Teo

  1. "Urology"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (20)
  3. Editorial (1)
Groups
  1. Department of Medicine (48)
  2. Genitourinary Oncology Service (48)
  3. Solid Tumor Oncology Division (48)
  4. Surgery (48)
  5. Urology (48)
  6. Department of Pathology and Laboratory Medicine (40)

More Groups

People
  1. Gopakumar Iyer (42)
  2. Jonathan Rosenberg (39)
  3. Dean Bajorin (37)
  4. Bernard Bochner (36)
  5. Hikmat Al-Ahmadie (36)
  6. David Solit (32)

More People

Years
  1. 2024 (7)
  2. 2023 (7)
  3. 2022 (10)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Modern Pathology (4)
  3. Clinical Cancer Research (3)
  4. Laboratory Investigation (3)
  5. Bladder Cancer (2)
  6. European Urology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. Nature Publishing Group (5)
  3. American Association for Cancer Research (4)
  4. Nature Research (4)
  5. Biomed Central Ltd (2)
  6. Cell Press (2)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer
    Meeting Abstract

    Aggen, D. H.; Shah, N. J.; Zheng, J.; Alam, S. M.; Balar, O.; Niederhausern, A.; Regazzi, A. M.; Ratna, N.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes
    Meeting Abstract

    Shah, N. J.; Aggen, D. H.; Zheng, J.; Niederhausern, A.; Alam, S. M.; Balar, O.; Bahadur, N.; Watson, A.; Regazzi, A. M.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
    Meeting Abstract

    Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma
    Meeting Abstract

    Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: A systematic review and meta-analysis
    Journal Article

    Chandran, E. B. A.; Iannantuono, G. M.; Atiq, S. O.; Akbulut, D.; Sinaii, N.; Simon, N. I.; Banday, A. R.; Boudjadi, S.; Gurram, S.; Nassar, A. H.; more...
    BMJ Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: Diagnostic performance and outcomes using biparametric vs. multiparametric MRI
    Journal Article

    Woo, S.; Becker, A. S.; Das, J. P.; Ghafoor, S.; Arita, Y.; Benfante, N.; Gangai, N.; Teo, M. Y.; Goh, A. C.; Vargas, H. A.
    Cancer Imaging (2023)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis
    Meeting Abstract

    Chandran, E.; Iannantuono, G. M.; Akbulut, D.; Atiq, S. O.; Gurram, S.; Teo, M. Y.; Coleman, J.; Sinaii, N.; Apolo, A. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save